Key terms

About PGNY

Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm’s network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest PGNY news

Apr 17 7:41am ET Analysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (EWTX) and Progyny (PGNY) by TipRanks Apr 02 7:25am ET Truist Financial Sticks to Its Buy Rating for Progyny (PGNY) by TipRanks Mar 14 7:25am ET Truist Financial Reaffirms Their Buy Rating on Progyny (PGNY) by TipRanks Feb 29 7:36am ET Progyny announces $100M share repurchase program by TipRanks Feb 28 8:40am ET Analysts Offer Insights on Healthcare Companies: ACADIA Pharmaceuticals (ACAD), Progyny (PGNY) and Protagonist Therapeutics (PTGX) by TipRanks Feb 28 7:37am ET Buy Rating Affirmed for Progyny Despite Seasonal Dip: Long-term Growth and Solid Fundamentals Justify Premium Valuation by TipRanks Feb 28 6:58am ET Progyny’s Strong Market Position and Growth Potential Merit a Buy Rating by TipRanks Feb 28 6:47am ET Progyny price target lowered to $43 from $45 at KeyBanc by TipRanks Feb 28 6:37am ET Progyny: A Positive Growth Outlook Justifies Buy Rating Despite Q4 Miss by TipRanks Feb 28 5:50am ET Progyny: A Strong Buy on Market Dominance and Promising Growth Trajectory by TipRanks Feb 28 4:49am ET KeyBanc Reaffirms Their Buy Rating on Progyny (PGNY) by TipRanks Feb 28 3:36am ET Progyny (PGNY) Receives a Buy from Barclays by TipRanks Feb 27 11:36pm ET Progyny: A Strong Buy Amidst Expansion and Growing Market Demand by TipRanks Feb 27 4:37pm ET Progyny sees Q1 EPS 33c-35c consensus 18c by TipRanks Feb 27 4:35pm ET Progyny sees FY24 EPS 1.54-$1.59, consensus $1.00 by TipRanks Feb 27 4:30pm ET Progyny reports Q4 EPS 13c, consensus 11c by TipRanks Feb 26 7:16am ET Progyny (PGNY) Receives a Buy from Truist Financial by TipRanks Feb 26 6:15am ET Progyny initiated with an Outperform at Leerink by TipRanks

No recent press releases are available for PGNY

PGNY Financials

1-year income & revenue

Key terms

PGNY Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

PGNY Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Jamie Dimon, Chairman and Chief Executive officer (CEO) of JPMorgan Chase & Co. (JPM) speaks to the Economic Club of New York in Manhattan in New York City, U.S., April 23, 2024. REUTERS/Mike Segar
Mike Segar/Reuters
Jamie Dimon fears for the future of the free world and US debt
A bubble tea store operated by Sichuan Baicha Baidao in Shanghai, China, on April 23, 2024.
Raul Ariano/Bloomberg/Getty Images
Is the tea bubble bursting? ChaPanda shares plunge in Hong Kong IPO
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Can markets make a comeback? That depends on tech earnings
People walk past the New York Stock Exchange Thursday, March. 21, 2024.
Yuki Iwamura/AP
Investors are fearful. They shouldn’t be